Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
![Foto de Terapia Génica en Enfermedad de Parkinson](/img/uploaded/2e47307b33b4171dbd01aab57609e63c.jpg)
![Foto de Universidad Autónoma de Madrid](/img/noimage_org.png)
Universidad Autónoma de Madrid
Madrid, EspañaPublications en collaboration avec des chercheurs de Universidad Autónoma de Madrid (3)
2021
-
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Acta Neuropathologica Communications, Vol. 9, Núm. 1
2018
-
Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
GLIA, Vol. 66, Núm. 8, pp. 1752-1762
1999
-
Thalamic interaction between the input and the output systems of the basal ganglia
Journal of Chemical Neuroanatomy, Vol. 16, Núm. 3, pp. 187-200